Adi Diab, MD

Cleveland Clinic Abu Dhabi

UAE

Scientific Director, Oncology Institute, Cleveland Clinic Abu Dhabi, UAE; Affiliated Faculty, Cleveland Clinic Foundation.

Ajlan Zaki, MD, PhD

Cleveland Clinic Abu Dhabi

UAE

Physician-scientist and Staff Physician at CCAD, specializing in lymphoma, leukemia, myeloma, and cellular therapies; Editorial Board member of Translational Cancer Research.

Alexandra Dreyfuss, MD, MSTR

University of Miami / Sylvester Comprehensive Cancer Center

USA

Executive Director of ILROG; leads global coordination, education, and publication of lymphoma RT guidelines.

Alison Moskowitz, MD

Memorial Sloan Kettering Cancer Center

USA

Co-author of the NCCN Hodgkin Lymphoma Guidelines, Clinical Director of the Lymphoma Inpatient Unit at MSKCC, and Editorial Board member of Haematologica, Acta Haematologica, and JCO Oncology Advances.

Anas Younes, MD, PhD

AstraZeneca

USA

Andrew Zelenetz, MD, PhD

Memorial Sloan Kettering Cancer Center

USA

Founding Chair of the NCCN Non-Hodgkin Lymphoma Panel and former Chief of the Lymphoma Service at MSKCC.

Bouthaina Dabaja, MD, FASTRO

The University of Texas MD Anderson Cancer Center

USA

Professor and Section Chief of Hematology, Division of Radiation Oncology
Professor, Department of Leukemia, Division of Cancer Medicine.
Incident Commander, Division of Radiation Oncology
University of Texas MD Anderson Cancer Center
Director of Research, International Lymphoma Radiation Oncology Group (ILROG)

Brandon Imber, MD

Memorial Sloan Kettering Cancer Center

USA

Radiation oncologist and Associate Director of Education in Lymphoma RT at MSKCC; active ILROG member.

Carla Hajj, MD

Cleveland Clinic Abu Dhabi

UAE

Radiation Oncologist and Director of Clinical Research at the Oncology Institute, CCAD; Editorial Board Member of Frontiers in Oncology and Hepatoma Research; active member of the NRG GI Hepatobiliary Working Group with expertise in ablative and particle therapies.

Caroline Samaha Jabbour, MD

Mount Lebanon Hospital

Lebanon

Former chief of Radiation Oncology at Mount Lebanon Hospital, Lebanon, graduate of Saint Joseph University, active researcher in health equity and access to radiation therapy.

Erel Joffe, MD

Tel Aviv Medical Center

Israel

Former Assistant Attending in Lymphoma at MSKCC and current Head of the Hemato Oncology Clinical Trials Unit at Tel Aviv Medical Center, specializing in lymphoma therapy; ILROG contributor.

Fady Geara, MD, PhD

Cleveland Clinic Abu Dhabi

UAE

Chair of Radiation Oncology at the Fatima Bint Mubarak Center, Cleveland Clinic Abu Dhabi, UAE.

Fatin Sammour, MD

Cleveland Clinic Abu Dhabi

UAE

Staff Physician in Medical Oncology & Hematology at CCAD with extensive UK and UAE experience in leukemia, lymphoma, and myeloma care.

George Mikhaeel, MD

Guy's & St Thomas' NHS Foundation Trust

UK

Consultant Radiation Oncologist and ILROG Steering Committee member; expert in imaging-adaptive RT at Guy's and St Thomas'.

Hamza Hashmi, MD

Memorial Sloan Kettering Cancer Center

USA

Assistant Attending, Myeloma & Cell Therapy Service, Memorial Sloan Kettering Cancer Center <br>Assistant Professor of Medicine.

Hans Theodor Eich, MD, PhD

University of Münster

Germany

Joachim Yahalom, MD

Memorial Sloan Kettering Cancer Center

USA

Founding Chair of ILROG and Director of Radiation Oncology for Lymphoma at MSKCC; global authority on lymphoma RT guidelines.

Julieta Osorio Zuluaga, MD

American Hospital Dubai

UAE

Consultant Hematologist, American Hospital Dubai.

Lara Hilal, MD

American University of Beirut Medical Center

Lebanon

Radiation Oncologist at the American University of Beirut Medical Center (AUBMC).

Lena Specht, MD

Copenhagen University Hospital

Denmark

Chair of Oncology and Director of the Lymphoma RT Program at Rigshospitalet, University of Copenhagen; ILROG founding member.

Louis "Sandy" Constine, MD

University of Rochester and Wilmot Cancer Institute

USA

Senior Radiation Oncologist at the University of Rochester and Wilmot Cancer Institute. He is internationally recognized for his work in pediatric cancers, lymphomas, and survivorship, and serves on NCCN guideline panels. He is also on the editorial boards of the International Journal of Radiation Oncology • Biology • Physics and the Journal of Adolescent and Young Adult Oncology, shaping advances in cancer care worldwide.

Mohamad Masri, MD

Cleveland Clinic Abu Dhabi

UAE

Staff physician at CCAD, board-certified in Hematology, Medical Oncology, and Internal Medicine, with expertise in leukemia, lymphoma, multiple myeloma, and stem cell transplantation.

Mohamed Abuhaleeqa, MD

Abu Dhabi Stem Cells Center

UAE

Consultant Hematologist & Bone Marrow Transplant Specialist; Chair of Academic Affairs, Abu Dhabi Stem Cells Center (ADSCC).

Paolo Caimi, MD

Cleveland Clinic Foundation

USA

Associate Professor at Case Western Reserve University, Associate Director of Cellular Therapy at Cleveland Clinic, and lymphoma expert leading clinical trials in CAR T-cell therapy, stem cell transplantation, and novel immunotherapies.

Paul Ramia, MD, FRCP

Cleveland Clinic Abu Dhabi

UAE

Consultant Radiation Oncologist, Cleveland Clinic Abu Dhabi.

Rehab Al-Blooshi, MD

University Hospital Sharjah

UAE

Consultant Hematologist & Medical Director, Cord & Blood Research Centre; Stem Cell Transplant Specialist, University Hospital Sharjah.

Roni Shouval, MD, PhD

Memorial Sloan Kettering Cancer Center

USA

Director, Precision Cellular Therapy Laboratory
Assistant Attending
.Adult BMT Service
Cellular Therapy Service
Memorial Sloan Kettering Cancer Center

Serra Kamer, MD

Ege University, Izmir

Turkey

Professor of Radiation Oncology at Ege University Faculty of Medicine, İzmir Fellowship in Radiosurgery and Conformal Radiotherapy at Vrije University, Netherlands Fellowship in IMRT techniques at Rambam Hospital, Israel (Middle East Cancer Consortium Grant) Research Fellow in Radiobiology at Thomas Jefferson University, USA

Shahrukh Hashmi, MD

Department of Health, Abu Dhabi

UAE

Global key opinion leader in the field of cancer, stem cells and Artificial Intelligence, Prof. Shahrukh Hashmi currently directs the Research at the Department of Health, Abu Dhabi, UAE; he practices as a professor of medicine at the Mayo Clinic (Minnesota, US) and is a professor (adjunct) of Computer Vision at MBZ-University of Artificial Intelligence (Abu Dhabi, UAE).

Shunan Qi, MD

Chinese Academy of Medical Sciences

China

Director of Radiation Oncology for Hematologic Malignancies at the Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; ILROG China representative.

Stephen R. Grobmyer, MD

Cleveland Clinic Abu Dhabi

UAE

Steven Horwitz, MD

Memorial Sloan Kettering Cancer Center

USA

Member and Attending Physician at Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College

Umberto Ricardi, MD

University of Turin

Italy

Professor and Chair of Radiation Oncology at University of Turin; Past-President of ESTRO.

Venkada Manickam, MD

National Centre for Cancer Care & Research

Qatar

Specialist in Radiation Oncology at Hamad Medical Corporation, Qatar (since January 2020) Registrar in Radiation Oncology at Max Cancer Centre, New Delhi, India (2012–2020) Senior Resident at Rajiv Gandhi Cancer Institute & Research Centre, Delhi (2010–2011)

Yaser Alkhatib, MD

Cleveland Clinic Abu Dhabi

UAE

Consultant Medical Oncologist at Burjeel Day Surgery Center, Al Reem Island, UAE Internal Medicine and Hematology/Oncology at Henry Ford Hospital/Wayne State University, where he served as Chief Fellow Assistant Professor at MD Anderson Cancer Center, Houston, Texas